Condensed Consolidated Statements of Operations (Unaudited) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Revenue	$ 49,000	$ 0	$ 50,000	$ 0
Cost of Goods Sold	65,000	0	92,000	0
Gross Margin	(16,000)	0	(42,000)	0
Research and development:
R&D costs, excluding stock-based compensation expense	301,000	287,000	660,000	513,000
Stock-based compensation expense related to options and warrants	(49,000)	21,000	(32,000)	53,000
Total research and development	252,000	308,000	628,000	566,000
General and administrative:
G&A costs, excluding stock-based compensation expense	275,000	223,000	607,000	534,000
Stock-based compensation expense related to options and warrants	79,000	158,000	75,000	355,000
Total general and administrative	354,000	381,000	682,000	889,000
Asset impairments	0	0	0	0
Total costs and expenses	606,000	689,000	1,310,000	1,455,000
Loss from operations	(622,000)	(689,000)	(1,352,000)	(1,455,000)
Other income	20,000	0	20,000	3,000
Loss before income tax benefits	(602,000)	(689,000)	(1,332,000)	(1,452,000)
Income tax benefits	0	0	0	0
Net Loss	(602,000)	(689,000)	(1,332,000)	(1,452,000)
Preferred stock beneficial conversion feature	0	0	4,250,000	0
Preferred stock dividends	66,000	66,000	132,000	132,000
Net Loss attributable to Torvec, Inc. common stockholders	$ (668,000)	$ (755,000)	$ (5,714,000)	$ (1,584,000)
Net Loss per common share attributable to stockholders of Torvec, Inc.:
Basic and Diluted (in Dollars per share)	$ (0.01)	$ (0.02)	$ (0.12)	$ (0.03)
Weighted average number of shares of common stock:
Basic and Diluted (in Shares)	45,716,000	45,716,000	45,716,000	45,716,000